Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
Stefania Kiapidou; Christina Liava; Maria Kalogirou; Evangelos Akriviadis; Emmanouil Sinakos;
Ann Hepatol. 2020;19:134-44
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease
Facundo Maiorana; Magali Neschuk; MarĂa Virginia Caronia; Karina Elizondo; Adolfo Schneider; Georgina Veron; Pedro D Zapata; Fernando Javier Barreyro;
10.1016/j.aohep.2024.101541